Clinical Research Directory
Browse clinical research sites, groups, and studies.
Doxycycline in Type II Diabetes
Sponsor: Mostafa Bahaa
Summary
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disease characterized by hyperglycemia, weight loss, and cardio-metabolic complications. T2DM develops due to the progression of insulin resistance (IR), impairment of insulin insensitivity, and failure of the pancreatic β-cells to release sufficient amount of insulin in response to glucose burden
Official title: Doxycycline in Combination With Sitagliptin on the Glycemic and Cardiac Indices in Patients With Type 2 Diabetes Mellitus
Key Details
Gender
All
Age Range
40 Years - 60 Years
Study Type
INTERVENTIONAL
Enrollment
60
Start Date
2024-03-30
Completion Date
2026-04-20
Last Updated
2025-04-04
Healthy Volunteers
No
Conditions
Interventions
Sitagliptin 100mg
Sitagliptin is used along with diet and exercise and sometimes with other medications to lower blood sugar levels in adults with type 2 diabetes
Doxycyclin
Doxycycline belongs to the class of medicines known as tetracycline antibiotics. It works by killing bacteria or preventing their growth.
Locations (1)
Tanta Unuversity
Tanta, Egypt